Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease.
about
Hodgkin's disease and the Epstein-Barr virus.Impaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse?Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implicationsType 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapyEBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinomaThe interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disordersRegulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal StudyEnhanced antitumor effect of combining chemotherapy with Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes in mice with EBV-related non-Hodgkin's lymphoma.Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions.Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function.Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cellsImmunotherapies for Hodgkin's lymphoma.Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells.
P2860
Q24535291-0AB09132-6215-440D-8C13-1F11BC64A083Q27003955-F37095B7-FC8A-4017-9422-67589C253624Q27011510-80583577-C241-4612-A6A6-BEB1A89E9E84Q30305830-7A734034-F632-4BD3-B392-5F6152BC211EQ33305203-754E398D-7943-41C6-92B5-365324B629E8Q33793531-740BE7F8-F692-41B1-8938-B18C3F6690AFQ34089491-376D9DC6-82FC-4FA8-88DD-AE6E5027FAF9Q34166602-A915FBD5-3A80-4B18-B507-7A6E0AC38BA3Q36235726-5CEE8D5D-5DC0-43DE-B178-657DE1C6DF22Q36334405-EBC2A5DE-44E4-4BC7-BC3F-8A5BFB397753Q36431400-519585AB-AE1A-4B45-A393-056558659CC1Q36623027-6EAE1E5C-68A9-4B75-B111-1879DF121BD0Q36641073-9A0E21AD-BEEA-4728-BE64-263B2AF98BAEQ36734903-4C9CB509-8A03-4406-AAF7-BE01EB15C361Q37006427-827F604D-8614-4786-8477-363600329AE6Q37623812-75F8A9EB-EA50-4C5F-B20E-B93F1D1C0C8C
P2860
Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Local suppression of Epstein-B ...... BV-positive Hodgkin's disease.
@en
Local suppression of Epstein-Barr virus
@nl
type
label
Local suppression of Epstein-B ...... BV-positive Hodgkin's disease.
@en
Local suppression of Epstein-Barr virus
@nl
prefLabel
Local suppression of Epstein-B ...... BV-positive Hodgkin's disease.
@en
Local suppression of Epstein-Barr virus
@nl
P2093
P921
P1433
P1476
Local suppression of Epstein-B ...... BV-positive Hodgkin's disease.
@en
P2093
Biberfeld P
Boiocchi M
Brautbar C
P304
P407
P577
1995-08-01T00:00:00Z